Pretzel Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pretzel Therapeutics's estimated annual revenue is currently $4.3M per year.(i)
  • Pretzel Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Pretzel Therapeutics has 56 Employees.(i)
  • Pretzel Therapeutics grew their employee count by 4% last year.

Pretzel Therapeutics's People

NameTitleEmail/Phone
1
Chairman and CEOReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Chairman and CEOReveal Email/Phone
4
Co-FounderReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Chief Scientific OfficerReveal Email/Phone
7
SVP - Head BiologyReveal Email/Phone
8
VP, ChemistryReveal Email/Phone
9
VP, DMPKReveal Email/Phone
10
VP FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Pretzel Therapeutics?

Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology. Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders. At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.

keywords:N/A

N/A

Total Funding

56

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M56-8%N/A
#2
$7.3M56-35%N/A
#3
$11.1M56N/AN/A
#4
$7.3M56-20%N/A
#5
$16.3M564%N/A